Business Information
The group's principal activities are to deliver chemistry products and services to pharmaceutical, agrochemical and biotechnology industries. The group provides integrated discovery software products, software consulting services and research services. The products are used in the pre-clinical phases of new pharmaceutical development, pre-approval phase of agrochemical product and product discovery phase of chemical research. The pharmaceutical clients include aventis, bayer, bristol-myers squibb, pfizer, and schering ag. The biotechnology clients include biovitrum, chronogen, and critical therapeutics. The group has operations in the United States, Europe, Germany, France and Pacific Rim.
|
|
Name |
Title
|
Email
|
| Ralph Lobdell | Chmn. | N/A | | Gregory Smith | CTO | N/A | | James Rubin | Sr. VP - Finance, CFO | N/A | | John Yingling | VP, Chief Accounting Officer | N/A | | Richard Cramer | Sr. VP - Science, Chief Scientific Officer | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 27,384 | (38,593) | | 2005 | 55,421 | (4,288) | | 2004 | 64,779 | 232
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
